NCT05682287

Brief Summary

The goal of this trial is to compare the effects 448kHz capacitive resistive monopolar radiofrequency (CRM) with Proprioceptive Neuromuscular Facilitation (PNF) versus only PNF in chronic low back pain patients. The main questions it aims to answer are:

  1. 1.Is there any difference in interventions on reduction of pain.
  2. 2.Is there any difference in interventions on reduction of disability.
  3. 3.448kHz capacitive resistive monopolar radiofrequency and,
  4. 4.PNF intervention

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 12, 2023

Completed
Last Updated

January 12, 2023

Status Verified

January 1, 2023

Enrollment Period

4 months

First QC Date

December 24, 2022

Last Update Submit

January 11, 2023

Conditions

Keywords

chronic low back pain448kHz capacitive resistive monopolar radiofrequencyrandomised controlled trialpaindisability

Outcome Measures

Primary Outcomes (2)

  • Change from baseline: Pain - Visual Analogue Scale (VAS)

    Change from baseline pain, measured by 0-10 Visual Analogue Scale (VAS). VAS has a minimum score of 0 and a maximum score of 10. Higher score indicates a worse outcome (e.g., greater pain intensity).

    Change from baseline pain after two weeks (14 days).

  • Change from baseline: Disability - ODI (Oswestry Low Back Pain Disability Questionnaire)

    Change from baseline disability, measured by Oswestry Low Back Pain Disability Questionnaire. ODI has a minimum score of 0% and maximum score of 100%. Higher score indicates a worse outcome (e.g., greater disability).

    Change from baseline disability after two weeks (14 days).

Secondary Outcomes (2)

  • Change from baseline: Disability - Quebec Back Pain Disability Scale (QBPD)

    Change from baseline disability after two weeks (14 days).

  • Change from baseline: Roland-Morris Disability Questionnaire (RMDQ)

    Change from baseline disability after two weeks (14 days).

Study Arms (2)

Experimental group

EXPERIMENTAL

Participants in the experimental group will be treated with a combination of 448kHz capacitive resistive monopolar radiofrequency and Proprioceptive neuromuscular facilitation (PNF) over the course of two weeks. 1. 448 kHz radio frequency therapy will be carried for a duration of 15 min. Contact cream will be applied beforehand to increase the electrical conductivity in the treated area. 2. After the radiofrequency therapy, participants will exercise for exactly 20 minutes using the PNF concept exercises to mobilize the pelvis and lumbar spine, primarily strengthening the muscles of the abdomen, back and hips. Therapy will be administered for a total of 5 times in two weeks. Three times in week 1 and two times in week 2.

Device: 448kHz capacitive resistive monopolar radiofrequencyOther: Proprioceptive Neuromuscular Facilitation

Control group

ACTIVE COMPARATOR

Participants will exercise for exactly 20 minutes, over the course of two weeks, using the PNF concept exercises to mobilize the pelvis and lumbar spine, primarily strengthening the muscles of the abdomen, back and hips. Therapy will be administered for a total of 5 times in two weeks. Three times in week 1 and two times in week 2. This is identical intervention and the second intervention in the experimental group.

Other: Proprioceptive Neuromuscular Facilitation

Interventions

Capacitive resistive monopolar radiofrequency (CRM) treatment is a type of medical procedure that uses radiofrequency energy to heat the targeted tissue.

Experimental group

Proprioceptive neuromuscular facilitation (PNF) is a type of physical therapy that uses techniques such as stretching and strengthening exercises to improve muscle function and movement patterns.

Also known as: PNF
Control groupExperimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • older than 18 years, chronic low back pain (CLBP)

You may not qualify if:

  • spinal fractures, radiculopathies, history of spinal surgery, spinal stenosis, history of thrombosis, pacemaker, pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Polyclinic Cerebellum

Varaždin, Varaždin County, 42000, Croatia

Location

Related Publications (1)

  • Jurak I, Grabar S, Zura N, Jakus L. Evaluating the Efficacy of Capacitive Resistive Monopolar Radiofrequency Combined With Proprioceptive Neuromuscular Facilitation in Managing Chronic Low Back Pain: A Randomised Controlled Trial. Physiother Res Int. 2025 Jan;30(1):e70009. doi: 10.1002/pri.70009.

MeSH Terms

Conditions

Low Back PainPain

Interventions

Muscle Stretching Exercises

Condition Hierarchy (Ancestors)

Back PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Physiotherapy

Study Record Dates

First Submitted

December 24, 2022

First Posted

January 12, 2023

Study Start

March 1, 2022

Primary Completion

June 30, 2022

Study Completion

July 1, 2022

Last Updated

January 12, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

Anonymized IPD will be shared either as a supplement to manuscript or on adequate server for storing IPD data. Data will always be available upon inquiry by email to lead investigators. All variables that were measured will be included in the dataset.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
When: Upon publication. How long: Indefinitely.
Access Criteria
Available to all. No criteria for accessing the data.

Locations